BioELife Corp. (LITH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
+0.0000 (0.00%)
At close: Oct 24, 2024

BioELife Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 2013 - 2009
Period Ending
Sep '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 2013 - 2009
Net Income
-0.59-0.34-0.25-0.21-0.08-0.5
Upgrade
Depreciation & Amortization
0-----
Upgrade
Other Amortization
00.050.10.090.030.01
Upgrade
Loss (Gain) From Sale of Assets
--0.68----
Upgrade
Loss (Gain) From Sale of Investments
0.480.82----
Upgrade
Stock-Based Compensation
-----0.01
Upgrade
Other Operating Activities
0.010.04---0.020.4
Upgrade
Change in Accounts Payable
0.010.030.030.020.020.02
Upgrade
Change in Other Net Operating Assets
-0.03-0-0-0.030.020.02
Upgrade
Operating Cash Flow
-0.12-0.08-0.12-0.13-0.03-0.04
Upgrade
Capital Expenditures
-0.01-0--0--
Upgrade
Sale of Property, Plant & Equipment
-0.06----
Upgrade
Investment in Securities
0.120----
Upgrade
Investing Cash Flow
0.110.06--0--
Upgrade
Short-Term Debt Issued
-0.020.120.140.03-
Upgrade
Long-Term Debt Issued
----0.010.03
Upgrade
Total Debt Issued
-0.020.120.140.030.03
Upgrade
Net Debt Issued (Repaid)
-0.020.120.140.030.03
Upgrade
Financing Cash Flow
-0.020.120.140.030.03
Upgrade
Net Cash Flow
-0.010-0.010.010-0
Upgrade
Free Cash Flow
-0.13-0.08-0.12-0.13-0.03-0.04
Upgrade
Free Cash Flow Per Share
-0.04-0.03-0.05-0.06-0.02-0.03
Upgrade
Levered Free Cash Flow
-0.21-0.03-0.03-0.06-0.01-0.25
Upgrade
Unlevered Free Cash Flow
-0.2-0.03-0.05-0.08-0.01-0.24
Upgrade
Change in Net Working Capital
0.13-0.02-0.030.01-0.03-0.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.